Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein

Assignee

• Astellas Pharma

Inventors

• Atsushi Suzuki (3 patents)
• Makoto Asaumi (4 patents)
• Kazuhisa Tsunoyama (4 patents)
• Kouichi Nishimura (60 patents)
• Akifumi Morinaka (8 patents)
• Tomohiro Yamauchi (2 patents)
• Masayasu Yoshino (4 patents)
• Hiroaki Yoshizaki (2 patents)

View full patent text on Google Patents →